These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 36032659)
1. Identification and Validation of an m6A-Related LncRNA Signature to Predict Progression-Free Survival in Colorectal Cancer. Zhang Y; Li L; Chu F; Xiao X; Zhang L; Li K; Wu H Pathol Oncol Res; 2022; 28():1610536. PubMed ID: 36032659 [TBL] [Abstract][Full Text] [Related]
2. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients. Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of N6-Methyladenosine-Related lncRNA Signature for Predicting Prognosis and Immune Cell Infiltration in Patients with Colorectal Cancer. Zhao Z; Yang YB; Li XY; Li XG; Chu XD; Lin ZB; Zhang YR; Guo YG; Ding H; Pan YL; Wang L; Pan JH Dis Markers; 2021; 2021():8686307. PubMed ID: 34745388 [TBL] [Abstract][Full Text] [Related]
4. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients. Fan Q; Liu B J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531 [TBL] [Abstract][Full Text] [Related]
5. Identification of N6-methylandenosine related lncRNA signatures for predicting the prognosis and therapy response in colorectal cancer patients. Li Z; Liu Y; Yi H; Cai T; Wei Y Front Genet; 2022; 13():947747. PubMed ID: 36246627 [TBL] [Abstract][Full Text] [Related]
6. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer. Song Y; Qu H BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619 [TBL] [Abstract][Full Text] [Related]
7. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer. Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M Front Immunol; 2022; 13():994874. PubMed ID: 36330513 [TBL] [Abstract][Full Text] [Related]
8. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer. Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777 [TBL] [Abstract][Full Text] [Related]
9. M6A-related lncRNAs predict clinical outcome and regulate the tumor immune microenvironment in hepatocellular carcinoma. Chen B; Yang Z; Lang Z; Tao Q; Zhang R; Zhan Y; Xu X; Zhu K; Zheng J; Yu Z; Yu S BMC Cancer; 2022 Aug; 22(1):867. PubMed ID: 35941582 [TBL] [Abstract][Full Text] [Related]
10. An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer. Ma T; Wang X; Meng L; Liu X; Wang J; Zhang W; Tian Z; Zhang Y BMC Cancer; 2021 Nov; 21(1):1256. PubMed ID: 34802433 [TBL] [Abstract][Full Text] [Related]
11. Identification of an m6A-related lncRNA prognostic signature in colorectal cancer. Shi ZL; Yang X; Shen CL; Zhou GQ J Biochem Mol Toxicol; 2023 Jan; 37(1):e23239. PubMed ID: 36205301 [TBL] [Abstract][Full Text] [Related]
12. Construction of an N6-methyladenosine lncRNA- and immune cell infiltration-related prognostic model in colorectal cancer. Yu ZL; Zhu ZM Protoplasma; 2022 Jul; 259(4):1029-1045. PubMed ID: 34734333 [TBL] [Abstract][Full Text] [Related]
13. A ten N6-methyladenosine-related long non-coding RNAs signature predicts prognosis of triple-negative breast cancer. Wu J; Cai Y; Zhao G; Li M J Clin Lab Anal; 2021 Jun; 35(6):e23779. PubMed ID: 33934391 [TBL] [Abstract][Full Text] [Related]
14. lncRNAs AC156455.1 and AC104532.2 as Biomarkers for Diagnosis and Prognosis in Colorectal Cancer. Kuang F; Luo D; Zhou M; Du J; Yang J Dis Markers; 2022; 2022():4872001. PubMed ID: 36277972 [TBL] [Abstract][Full Text] [Related]
15. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma. Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168 [No Abstract] [Full Text] [Related]
16. Construction and validation of stemness-related lncRNA pair signature for predicting prognosis in colorectal cancer. Thandar M; Zhu Y; Zhang X; Chen Z; Zhao Y; Huang S; Chi P J Cancer Res Clin Oncol; 2023 Oct; 149(13):11815-11828. PubMed ID: 37410143 [TBL] [Abstract][Full Text] [Related]
17. Identification and Validation of a Novel 2-LncRNAs Signature Associated with m6A Regulation in Colorectal Cancer. Wang K; Zhao B; Liang Y; Ma B J Cancer; 2022; 13(1):21-33. PubMed ID: 34976168 [TBL] [Abstract][Full Text] [Related]
18. Construction and validation of N6-methyladenosine long non-coding RNAs signature of prognostic value for early biochemical recurrence of prostate cancer. Liu J; Zhang W; Wang J; Lv Z; Xia H; Zhang Z; Zhang Y; Wang J J Cancer Res Clin Oncol; 2023 May; 149(5):1969-1983. PubMed ID: 35731271 [TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway. Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164 [TBL] [Abstract][Full Text] [Related]
20. N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells. Lai J; Zhou Z; Hu K; Yu H; Su X; Niu X; Li H; Mao S Epigenetics; 2024 Dec; 19(1):2298058. PubMed ID: 38145548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]